Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Real-time vaccine safety surveillance for the early detection of adverse events.

Real-time vaccine safety surveillance for the early detection of adverse events. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Real-time vaccine safety surveillance for the early detection of adverse events. Abstract Text:

    tracy a lieuTracy A Lieu,martin kulldorffMartin Kulldorff,robert l davisRobert L Davis,edwin m lewisEdwin M Lewis,eric weintraubEric Weintraub,katherine yihKatherine Yih,ruihua yinRuihua Yin,jeffrey s brownJeffrey S Brown,richard plattRichard Platt, ,

    BACKGROUND: Rare but serious adverse events associated with vaccines or drugs are often nearly impossible to detect in prelicensure studies and require monitoring after introduction of the agent in large populations. Sequential testing procedures are needed to detect vaccine or drug safety problems as soon as possible after introduction. OBJECTIVE: To develop and evaluate a new real-time surveillance system that uses dynamic data files and sequential analysis for early detection of adverse events after the introduction of new vaccines. RESEARCH DESIGN: The Centers for Disease Control and Prevention (CDC)-sponsored Vaccine Safety Datalink Project developed a real-time surveillance system and initiated its use in an ongoing study of a new meningococcal vaccine for adolescents. Dynamic data files from 8 health plans were updated and aggregated for analysis every week. The analysis used maximized sequential probability ratio testing (maxSPRT), a new signal detection method that supports continuous or time-period analysis of data as they are collected. RESULTS: Using the new real-time surveillance system, ongoing analyses of meningococcal conjugate vaccine (MCV) safety are being conducted on a weekly basis. Two forms of maxSPRT were implemented: an analysis using concurrent matched controls, and an analysis based on expected counts of the outcomes of interest, which were estimated based on historical data. The analysis highlights both theoretical and operational issues, including how to (1) choose appropriate outcomes and stopping rules, (2) select control groups, and (3) accommodate variation in exposed:unexposed ratios between time periods and study sites. CONCLUSIONS: Real-time surveillance combining dynamic data files, aggregation of data, and sequential analysis methods offers a useful and highly adaptable approach to early detection of adverse events after the introduction of new vaccines.

    Real-time vaccine safety surveillance for the early detection of adverse events. Publishing Authors By Initials

    ta lieuTA Lieu,m kulldorffM Kulldorff,rl davisRL Davis,em lewisEM Lewis,e weintraubE Weintraub,k yihK Yih,r yinR Yin,js brownJS Brown,r plattR Platt, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Real-time vaccine safety surveillance for the early detection of adverse events. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Medical care

    VOLUME: 45

    Page Numbers: S89-95

    Journal Abbreviation:

    ISSN: 0025-7079

    DAY: 20

    MONTH: Oct

    YEAR: 2007

    Real-time vaccine safety surveillance for the early detection of adverse events. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 230027

    Real-time vaccine safety surveillance for the early detection of adverse events. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Real-time vaccine safety surveillance for the early detection of adverse events. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Real-time vaccine safety surveillance for the early detection of adverse events.

    AFFILIATION: Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA. tracy_lieu@harvardpilgrim.org

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Med Care

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Real-time vaccine safety surveillance for the early detection of adverse events Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News